Adding cilostazol to a dual-antiplatelet treatment protocol of aspirin and clopidogrel is as safe and effective as a double-dose dual protocol for preventing blood clots in angioplasty patients, according to a study presented at a cardiology meeting. After a month, serious bleeding, cardiovascular-related death, myocardial infarction or stroke was seen in 1.2% of triple therapy patients, compared with 1.4% of patients receiving double-dose dual therapy. The trial will monitor patients for three more years.
Study: Triple-drug protocol safe, effective for preventing clots
SmartBrief Job Listings for Health Care
|Chief Financial Officer||
B. E. Smith
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|